sglt2 inhibitor glp 1 agonist combination Effect of treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study SGLT2 inhibitors + GLP-1 RAs

: weight

J.NewsomeP

In 14 patients with coronary artery disease and good LV function, intravenous GLP-1 infusion improved global and regional wall LV function on dobutamine stress echocardiography compared with control [92]

Food and Drug Administration (FDA) have identified a potential link between gastroparesis and Ozempic, as well as other side effects that were not adequately disclosed to users or the medical community

The benefits of semaglutide in obese HFpEF patients were established in the landmark STEP HFpEF trial

PCOS is diagnosed when a patient has irregular cycles and clinical hyperandrogenism, or irregular cycles and biochemical hyperandrogenism, or either irregular cycles or hyperandrogenism alone plus, in adults, polycystic morphology on ultrasonography or elevated antimllerian hormone levels (Figure 1)